Shanghai Menon Animal Nutrition Technology Co., Ltd. Class A

Shanghai Menon Animal Nutrition Technology Co., Ltd. Class A

SSZSE:301156
9.98
CNY
-0.13
(-1.29%)
0.23EPS
51.53P/E
2.17BMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.86
1.96
2.96
3.86
2.92
2.67
2.62
3.06
3.88
Basic EPS, GAAP
0.17
0.24
0.47
0.5
0.32
0.33
0.26
0.3
0.23
Free Cash Flow per Basic Share
0.05
0.3
0.12
-0.25
-0.05
0.11
0.06
-0.28
- -
Dividend per Share
0.13
0.11
0.21
0.02
0.02
0.25
0.33
0.25
0.23
Book Value per Share
2.78
3.06
1.79
2.28
4.13
4.22
3.95
3.99
4.07
Tangible Book Value per Share
2.57
2.85
1.69
2.07
3.98
4.07
3.6
3.63
3.8
Basic Weighted Avg Shares
143
143
142
141
166
189
187
183
183
Sales/Revenue/Turnover
266
280
421
546
483
504
490
561
711
Operating Margin (%)
9.03
13.57
19.31
14.43
11.73
11.07
10.24
11.04
8.77
Depreciation Expense
6
7
7
9
11
20
24
27
- -
Net Income, GAAP
24
34
67
71
52
63
50
55
42
Effective Tax Rate (%)
8.16
11
12.43
11.28
9.94
10.22
11.14
9.81
10.82
Profit Margin (%)
9.08
12.28
15.86
12.92
10.86
12.5
10.12
9.77
5.88
Working Capital
125
142
140
162
513
523
443
316
361
LT Debt
- -
- -
7
67
1
- -
- -
- -
- -
Total Equity
197
217
254
324
782
799
745
730
750
Return on Invested Capital (%)
- -
17.34
31.2
21.52
8.74
7.59
6.3
7.43
- -
Return on Capital (%)
- -
17.13
27.93
20.69
8.7
7.93
6.41
7.43
- -
Return on Common Equity (%)
- -
16.59
28.36
24.42
9.49
7.98
6.42
7.43
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
183
183
184
Market Capitalization
2,609
1,989
2,165

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
452
415
444
Cash, Cash Equivalents & STI
167
138
175
Accounts Receivable, Net
123
118
138
Inventories
115
114
88
Total Current Liabilities
113
79
83
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
32.48%
-1.96%
Free Cash Flow
- -
-275.13%
-557.63%
Net Income, GAAP
- -
-2.11%
10.54%
Sales/Revenue/Turnover
- -
6.89%
14.56%
Total Cash Common Dividend
- -
282.01%
-25.97%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
98
110
132
150
490
2025
100
136
- -
171
561
2026
159
169
212
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.06
0.06
0.1
0.26
2025
0.05
0.08
- -
0.08
0.3
2026
0.07
0.03
0.05
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.33
- -
- -
0.33
2025
- -
- -
- -
- -
0.25
2026
0.08
0.15
- -
- -
- -

Company Description

CEO
Wei Hong
Full Time Employees
461
Sector
Consumer non-durables
Industry
Food: specialty/candy
Address
No. 151 Lihong Road Shanghai SH China 201807
IPO Date
Jun 17, 2022
Business
Shanghai Menon Animal Nutrition Technology Co., Ltd. engages in the research, development, production, and sale of feed additives and enzymatic protein feed raw materials primarily in China with exports to Asia, Europe, North America, South America, Africa, Oceania, and other international markets; founded in 1997 and headquartered at No. 151 Lihong Road, Jiading District, Shanghai, China. The company offers a comprehensive portfolio of products including food attractants, sweeteners, acidulants, plant extracts, sodium butyrate, butyric acid glyceride, emulsifiers, small peptides, fragrances, acidity regulators, flavoring agents such as Menaroma Fruity Series in flavors including banana, cherry almond, strawberry, raspberry, orange, apple, tutti frutti, and green grass, slow-release nitrogen sources, rumen-bypass amino acids, rumen-pass vitamins, mineral elements, and enzymatic hydrolysis of vegetable proteins; these solutions target animal breeding sectors for pigs, ruminants, poultry, and aquatic products, enhancing feed intake, palatability, gut health, nutrient absorption, and overall productivity while supporting antibiotic-free and sustainable farming practices. Recent developments include the commissioning of a dedicated production line for Menacid MT, a slow-release benzoic acid product that bolsters gut health and nutrient utilization in livestock; plans to establish a wholly-owned subsidiary for a 0.1 million ton annual corn protein processing project with an investment of approximately CNY 391 million; an investment agreement signed by its subsidiary with the Leling Economic Development Zone Management Committee in Shandong; establishment of a new company with CNY 100 million capital for biobased materials manufacturing; completion of a share repurchase program totaling 4.4068 million shares for CNY 61.0005 million; and a proposed 2025 restricted stock incentive plan alongside approval of an interim profit distribution plan.